David J. Moss

This profile gathers the share dealings of David J. Moss across 3 companies, led by Inmune Bio, Inc., Pegasi Energy Resources Corporation. and Tonix Pharmaceuticals Holding Corp. In total, 27 filings cover trades dated from 1 February 2008 to 2 July 2026.

Both buying and selling appear: 17 purchases worth €502k, against 6 sales worth €497k. Netting one side against the other leaves €4,831 of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 share grants and 2 option exercises.

A typical purchase (the median) is worth €19k. Clusters matter here: 13 out of 14 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 14 purchases old enough to measure, the stock rose over the following 90 days in 21% of cases; the median change was -29.1%. They describe history only and say nothing certain about the share price ahead.

The record was last updated on 7 July 2026 with an option exercise (€11k) in Inmune Bio, Inc. The clock since the last published purchase (30 September 2024) now reads 769 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.